If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.50    0.00 (0.00%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £7.38m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Final consideration for iTrack transfer

10 Sep 2020 07:00

RNS Number : 5452Y
Transense Technologies PLC
10 September 2020
 

Transense Technologies plc

 

("Transense" or the "Company")

 

Transense agrees final consideration relating to the transfer of the operational business and trading assets relating to iTrack, to Bridgestone Corporation, Japan ("Bridgestone")

 

Transense Technologies plc, the provider of specialist sensor systems, previously announced that on 24 June 2020 the Company granted an exclusive worldwide licence to ATMS Technology Limited ("ATMS"), a wholly owned subsidiary of Bridgestone, covering all current and future iTrack technology for a period of ten years.

 

In order to capitalise fully on the market potential of the use of the technology, the operational business and trading assets relating to the iTrack system were transferred to ATMS at provisional net asset value of approximately US$1.01m for cash consideration. The amount of the final consideration for the transfer has now been agreed by the parties at US$1.31m, comprising the agreed value of the operational business and trading assets transferred of US$3.26m, less the repayment of working capital loans totalling US$1.95m.

 

The above sums will be reflected in the final audited results for the year ended 30 June 2020 which are planned to be released in late October 2020.

 

 

The Company announces that the website address, at which the information required by AIM Rule 26 can be found, has changed to www.transense.com.

 

For further information please visit www.transense.com or contact:

 

Transense Technologies plc

Nigel Rogers, Executive Chairman

Melvyn Segal, Chief Financial Officer

Tel: +44 (0) 1869 238380

finnCap

Ed Frisby, Giles Rolls, Matthew Radley (Corporate Finance)

Tim Redfern, Tim Harper (ECM)

Tel: +44 (0) 20 7220 0500

 

 

About Transense Technologies

 

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. The directors believe that Transense's Surface Acoustic Wave (SAW) wireless, battery-less sensor systems offer advantages over legacy wireless sensor systems. Transense is targeting the torque, temperature and pressure sensing markets via its SAWSense division. The Translogik division offers a range of tyre testing equipment aimed at fleet managers and tyre service providers. Further details are available at www.transense.com.

 

Transense's shares are admitted to trading on AIM (AIM: TRT).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGGLGLVGGZZ
Date   Source Headline
23rd Nov 20163:45 pmRNSResult of AGM & Share Consolidation
23rd Nov 20167:00 amRNSAGM Statement
21st Sep 20167:00 amRNSNotice of AGM
21st Sep 20167:00 amRNSFinal Results
25th Aug 20167:00 amRNSInvestor Event
16th Aug 20167:00 amRNSNotice of Results
18th Jul 20167:01 amRNSTrading Update
18th Jul 20167:00 amRNSLicence Agreement with GE
9th Mar 20162:55 pmRNSHolding(s) in Company
2nd Mar 20167:00 amRNSInterim Results
16th Dec 20157:00 amRNSTranslogik Contract Win with Continental
16th Nov 20153:55 pmRNSResult of AGM
16th Nov 20157:00 amRNSAGM Statement
22nd Oct 20157:00 amRNSDirector Dealing
21st Oct 20157:00 amRNSSale of IntelliSAW Division for US$5m
8th Oct 20157:00 amRNSNotice of AGM and Posting of Accounts
28th Sep 20157:00 amRNSPreliminary unaudited results
13th Aug 20157:00 amRNSNew Translogik iTrack Contract Win
29th Jul 201512:36 pmRNSHolding(s) in Company
27th Jul 20151:30 pmRNSResult of General Meeting
27th Jul 20157:00 amRNSGM Statement & Result of Offer for Subscription
16th Jul 20157:00 amRNSRe: Open Offer
29th Jun 20157:00 amRNSPlacing and Offer for Subscription
1st May 20157:00 amRNSTranslogik Probe Used by Bosch
9th Apr 20157:00 amRNSFurther Translogik iTrack Contract Win
12th Mar 20157:00 amRNSRe Contract
9th Mar 20157:00 amRNSHalf Yearly Report
9th Mar 20157:00 amRNSRe Contract
6th Jan 20152:28 pmRNSHolding(s) in Company
30th Dec 201411:02 amRNSDirector Dealing
22nd Dec 20147:00 amRNSDirectorate Change
27th Nov 20145:42 pmRNSResult of AGM
27th Nov 20147:00 amRNSAGM Statement
20th Nov 20147:00 amRNSInitial OptiTread order for Snap-On Equipment
18th Nov 20144:46 pmRNSRelease of early warning PD detection system
28th Oct 20147:15 amRNSLaunch of 'Opti-Tread' with US partner
23rd Oct 20147:00 amRNSNotice of AGM and Posting of Accounts
23rd Sep 20141:00 pmRNSDirector Dealing
17th Sep 20147:00 amRNSPreliminary Results
16th Sep 20147:00 amRNSChange of Registered Office
8th Sep 20147:00 amRNSNotice of Results
10th Jul 201410:24 amRNSExercise of Warrants
13th Jun 20147:00 amRNSTrading Statement
4th Jun 20143:13 pmRNSExercise of Warrants and Exercise of Options
14th May 20145:30 pmRNSHolding(s) in Company
13th May 20145:30 pmRNSExercise of Warrants
30th Apr 20143:25 pmRNSExercise of Warrants
28th Mar 20145:32 pmRNSExercise of Warrants
10th Mar 20143:51 pmRNSHolding(s) in Company
7th Mar 20147:00 amRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.